By Laurence Swift (retired vet):
Using several different techniques, the WPI have found XMRV in 98 or 99% of their ME patients – how can the pyschs & other deniers deny a “link”?
The WPI have never claimed a causal relationship – in writing – but that firm link indicates there may be, to anyone of modest intelligence.
Anyone who has read the obligatory tome “Osler’s Web” will know the facts. Dr Paul Cheney, around 1985, took some of his ME patients’ MR scans to an MRI expert, who showed him a set of identical scans – from AIDS patients. (see the videos on YouTube). Maybe they hadn’t sorted out the retroviral origin of AIDS at that time, but the penny will have dropped later.
So we then knew a retrovirus was involved.
Then in 1991 the Wistar Institute researcher Elaine DeFreitas actually found a retrovirus in her ME patients, even showed electron-micrographs of the virus inside mitochondria where they disrupt the mitochondrial function of producing energy in the cell – hence the weakness or fatigue felt by patients. She couldn’t continue with the research as her funding was promptly withdrawn.
Also, just ask any freshly-infected M.E. patient what happened at the beginning? Most will describe a virus-like acute onset, thinking it to be merely flu or an Epstein-Barr relapse. They don't know that a retroviral infection can recruit and invade most of our NK (natural killer) blood cells and use them to multiply very rapidly before spreading everywhere in the body and especially in the brain.
With all the government institutions turning their back on the biomedical cause of M.E., it was left to the “private sector” to fill the deficit.
The Whittemore family, with their daughter Andrea an M.E. patient, engaged retrovirology experts including Judy Mikovits and established a private research centre, the Whittemore-Peterson Institute (WPI). Judy already suspected a retrovirus was involved and set out to prove it to the high standards of Science magazine.
The rest is history. Several ME patients have started on ART’s (anti-retroviral therapies) and are blogging about their experiences – most are improving. The drugs are based on those developed for treating AIDS patients.
However XMRV is not the same as HIV and it may be possible to develop special drugs for XMRV which will be more effective – if the drugs companies remove their collective skulls from their colons and get on with the job.
With perhaps seventeen million people worldwide affected, this could be very profitable.
— Laurence Swift (retired vet).